Aging is the greatest risk factor for the most detrimental diseases on earth, and finding therapies holds the potential to dramatically reduce disease. We're adding a new approach to this search that combines experimental biology and engineering into a high-throughput drug discovery engine. Our machine learning-based platform shortens the timeframe for experimentation and, in doing so, reduces the wait between research breakthroughs and promising therapies.

Location
California
GC backed since
2017
IPO

Related Perspectives

No items found.